BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/4/2014 11:47:00 AM | Browse: 1053 | Download: 890
 |
Received |
|
2013-09-30 08:26 |
 |
Peer-Review Started |
|
2013-10-01 20:57 |
 |
To Make the First Decision |
|
2013-10-22 16:22 |
 |
Return for Revision |
|
2013-10-23 16:19 |
 |
Revised |
|
2013-11-19 05:57 |
 |
Second Decision |
|
2013-12-05 19:26 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-12-06 12:07 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-01-06 09:53 |
 |
Publish the Manuscript Online |
|
2014-02-19 16:57 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Topic Highlights |
Article Title |
Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas
|
Manuscript Source |
Invited Manuscript |
All Author List |
Marta-Isabel Pereira and José Augusto Medeiros |
Funding Agency and Grant Number |
|
Corresponding Author |
Marta-Isabel Pereira, MD, PhD, Institute of Physiology, Faculty of Medicine, University of Coimbra, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal. jmedeiros@fmed.uc.pt |
Key Words |
Mucosa-associated lymphoid tissue lymphoma; Marginal zone lymphoma; Helicobacter pylori; Gastric lymphoma; Eradication therapy; Nuclear factor-kappa B pathway |
Core Tip |
Mucosa-associated lymphoid tissue (MALT) lymphomas are indolent B-cell lymphomas, originating in acquired MALT induced as a response to a chronic immunoinflammatory stimulus, notably infection by Helicobacter pylori (H. pylori). Antigenic stimulation determines lymphoid hyperplasia; additional genetic aberrations activate survival pathways, with the emergence of a malignant clone. The digestive system (predominantly the stomach) is the most frequent location, reflecting contact with foreign antigens, mucosal permeability and intrinsic lymphoid system. Early-stage gastric MALT lymphoma can regress through the eradication of H. pylori. Immortalizing genetic abnormalities, advanced disease or eradication-refractoriness require treatment alternatives, presently not consensual. Representative clinical trials are needed to optimize patient care. |
Publish Date |
2014-02-19 16:57 |
Citation |
Pereira MI, Medeiros JA. Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas. World J Gastroenterol 2014; 20(3): 684-698 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i3/684.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i3.684 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345